Literature DB >> 5550548

Congenital afibrinogenemia. Vascular changes and multiple thromboses induced by fibrinogen infusions and contraceptive medication.

H H MacKinnon, J F Fekete.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5550548      PMCID: PMC1930972     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  Precipitating antifibrinogen antibody appearing after fibrinogen infusions in a patient with congenital afibrinogenemia.

Authors:  A DE VRIES; T ROSENBERG; S KOCHWA; J H BOSS
Journal:  Am J Med       Date:  1961-03       Impact factor: 4.965

2.  Congenital afibrinogenemia; report of a case.

Authors:  H A LAWSON
Journal:  N Engl J Med       Date:  1953-03-26       Impact factor: 91.245

3.  F.d.d. Scientists agree with u.k. ;Pill' findings.

Authors:  G Waring
Journal:  Can Med Assoc J       Date:  1970-04-25       Impact factor: 8.262

Review 4.  Medical aspects of oral contraceptives.

Authors:  N J Elgee
Journal:  Ann Intern Med       Date:  1970-03       Impact factor: 25.391

5.  Congenital disorders of fibrinogen.

Authors:  D P Jackson; E A Beck; P Charache
Journal:  Fed Proc       Date:  1965 Jul-Aug

6.  Cryoprecipitates in treatment of congenital fibrinogen deficiency. Case report.

Authors:  P G Hattersley; M L Dimick
Journal:  Transfusion       Date:  1969 Sep-Oct       Impact factor: 3.157

7.  Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs.

Authors:  W H Inman; M P Vessey; B Westerholm; A Engelund
Journal:  Br Med J       Date:  1970-04-25
  7 in total
  4 in total

Review 1.  Thrombosis in Inherited Fibrinogen Disorders.

Authors:  Wolfgang Korte; Man-Chiu Poon; Alfonso Iorio; Michael Makris
Journal:  Transfus Med Hemother       Date:  2017-03-14       Impact factor: 3.747

Review 2.  Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.

Authors:  I F Godsland; U Winkler; O Lidegaard; D Crook
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

Review 3.  Treatment of congenital fibrinogen deficiency: overview and recent findings.

Authors:  Konstantinos Tziomalos; Sofia Vakalopoulou; Vassilios Perifanis; Vassilia Garipidou
Journal:  Vasc Health Risk Manag       Date:  2009-10-12

4.  Time course of haemostatic effects of fibrinogen concentrate administration in aortic surgery.

Authors:  C Solomon; C Hagl; N Rahe-Meyer
Journal:  Br J Anaesth       Date:  2013-02-06       Impact factor: 9.166

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.